Belite Bio (BLTE) shares rose 10% in Friday trading after Canaccord Genuity initiated coverage of the stock with a buy rating and a price target of $303.
Intraday trading topped 510,150 shares, compared with the daily average of 188,179.
Price: 188.98, Change: +17.89, Percent Change: +10.46
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments